Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Highest Cash (MYL, SLXP, HITK, AKRX)

Below are the top drugs-generic stocks on the NASDAQ in terms of cash. Mylan Inc MYL had $641.03 million in total cash for the latest quarter. Meanwhile, MYL's total debt stood at $5.41 billion. Salix Pharmaceuticals Ltd SLXP had $491.47 million in total cash and $319.99 million in total debt for the latest quarter. Hi-Tech Pharmacal Co Inc HITK had $45.19 million in total cash and $756.00 thousand in total debt for the latest quarter. Akorn Inc AKRX had $9.50 million in total cash for the latest quarter. AKRX's total debt for the same period amounted to $5.85 million. Trading Ideas.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: MarketsTrading IdeasDrugs-Generic IndustryHealth Carehighest cashNASDAQPharmaceuticals
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!